title: The cell envelope-bound metalloprotease (camelysin) from Bacillus cereus is a possible pathogenic factor.
abstract: A novel membrane proteinase of the nosocomial important bacteria species Bacillus cereus (synonyms: camelysin, CCMP) was purified up to homogeneity as was shown by mass spectrometry in its amphiphilic form. Camelysin is a neutral metalloprotease with a molecular mass of 19 kDa. Its unique N-terminus Phe-Phe-Ser-Asp-Lys-Glu-Val-Ser-Asn-Asn-Thr-Phe-Ala-Ala-Gly-Thr-Leu-Asp-Leu-Thr-Leu-Asn-Pro-Lys-Thr-Leu-Val-Asp-(Ile-Lys-Asp)- was not detected in the protein data bases during BLAST searches, but in the partially sequenced genome of Bacillus anthracis, coding for an unknown protein. Cleavage sites of the membrane proteinase for the insulin A- and B-chains were determined by mass spectrometry and N-terminal sequencing. Camelysin prefers cleavage sites in front of aliphatic and hydrophilic amino acid residues (-OH, -SO3H, amido group), avoiding bulky aromatic residues. The internally quenched fluorogenic substrates of the matrix metalloproteases 2 and 7 were cleaved with the highest efficiency at the Leu-decrease-Gly or Leu-decrease-Ala bond with the smaller residue in the P1' position. The protein specificity is broad--all various kinds of casein were cleaved as well as acid-soluble collagen, globin and ovalbumin; intact insulin was destroyed only to a low extent. Actin, collagen type I, fibrinogen, fibrin, alpha2-antiplasmin and alpha1-antitrypsin were cleaved. The protease formed SDS-stable complexes with Glu-plasminogen and antithrombin III, visible after SDS electrophoresis by gold staining and Western blot. The CCMP-plasminogen complex caused a partial activation of plasminogen to plasmin. Camelysin interacts with proteins of the blood coagulation cascade and could facilitate the penetration of fibrin clots and of the extracellular matrix during bacterial invasion.
authors.affiliation: Institute of Physiological Chemistry, Medical Faculty, Martin Luther University, Halle, Saale, Germany. beate.fricke@medizin.uni-halle.de
authors.forename: B
authors.initials: B
authors.lastname: Fricke
authors.forename: K
authors.initials: K
authors.lastname: Drössler
authors.forename: I
authors.initials: I
authors.lastname: Willhardt
authors.forename: A
authors.initials: A
authors.lastname: Schierhorn
authors.forename: S
authors.initials: S
authors.lastname: Menge
authors.forename: P
authors.initials: P
authors.lastname: Rücknagel
mesh_terms: D000595:Amino Acid Sequence; D001409:Bacillus cereus / Q000201:enzymology* / Q000472:pathogenicity; D001425:Bacterial Outer Membrane Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism*; D007328:Insulin / Q000737:chemistry / Q000378:metabolism; D007700:Kinetics; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors / Q000302:isolation & purification / Q000378:metabolism*; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000737:chemistry; D010958:Plasminogen / Q000378:metabolism; D011108:Polymers; D011480:Protease Inhibitors / Q000494:pharmacology; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D013379:Substrate Specificity
chemical_list: D001425:Bacterial Outer Membrane Proteins; D007328:Insulin; D010446:Peptide Fragments; D011108:Polymers; D011480:Protease Inhibitors; D010958:Plasminogen; C041725:butyl-Toyopearl 650; D008666:Metalloendopeptidases; C438729:camelysin